FIELD: pharmaceuticals.
SUBSTANCE: invention refers to a method of treating a dermatological disorder specified in a group consisting of fine lines, wrinkles and age spots. Method comprises topical administration to a patient of a composition comprising a therapeutically effective amount of a compound comprising an N-lipoic amino acid or peptide derivative, having following formula (I): N-lipoic acid-(X)n-ZR1 Formula (I). Lipoic is a lipoic (Lp) radical, (X)n is a peptide having n amino acid residues, wherein each of amino acid residues X is independently selected from any amino acid, n is an integer relating to range of 0–2, Z is a carboxy-terminal amino acid residue, wherein each of the amino acid residues is independently selected from any amino acid, R1 denotes NHR3, R3 denotes H. Invention also discloses use of a therapeutic composition containing a compound of formula (I) and use of the compound of formula (I).
EFFECT: technical result of the disclosed method consists in using stable lipoic acid derivatives for treating a dermatologic disorder.
7 cl, 8 dwg, 9 ex
Title | Year | Author | Number |
---|---|---|---|
PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
HIGH-PENETRATION PRODRUG COMPOSITIONS BASED ON PEPTIDES AND PEPTIDE-RELATED COMPOUNDS | 2010 |
|
RU2767051C2 |
PEPTIDES AND THEIR DERIVATIVES WHICH INTERACT WITH NICOTINIC ACETYLCHOLINE RECEPTOR AND SUITABLE FOR USE IN COSMETOLOGY AGAINST MIMIC AND AGE-RELATED WRINKLES | 2013 |
|
RU2524428C1 |
PEPTIDE ANTAGONISTS OF CALCITONIN CGRP FAMILY OF PEPTIDE HORMONES AND THEIR USE | 2017 |
|
RU2742826C2 |
PEPTIDE ANTAGONISTS OF PEPTIDE HORMONES FROM THE CALCITONIN GROUP (CALCITONIN GENE-RELATED PEPTIDES (CGRP)) AND THEIR APPLICATION | 2013 |
|
RU2624016C2 |
NOVEL OXYNTOMODULIN DERIVATIVES AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM FOR TREATING OBESITY | 2012 |
|
RU2739209C2 |
NOVEL ISOFORM OF TRYPSIN AND USE THEREOF | 2016 |
|
RU2814729C2 |
FUSED MOLECULES DERIVED FROM CHOLIX-TOXIN FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE LOADS | 2015 |
|
RU2723178C2 |
COMPLEMENT ACTIVITY MODULATION | 2015 |
|
RU2778514C2 |
PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
Authors
Dates
2020-11-27—Published
2016-03-14—Filed